Pfizer provides access to safe and effective and affordable medicines and health care services. They have a portfolio of products and medicines that support wellness and prevention, as well as treatment and cures for diseases across a broad range of therapeutic areas; and they have an industry-leading pipeline of promising new products that have the potential to challenge some of the most feared diseases of their time, like Alzheimer's disease and cancer.

Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs as well as vitamins and other consumer healthcare products. The firm also has a crop science business that includes seeds, pesticides, herbicides, and fungicides, which was expanded through its 2018 acquisition of Monsanto.

Operator of a Regenerative Medicine company that provides stem cell technologies, products, and therapies. The entity partners with medical facilities globally and assists medical device companies with business development. Located in Miami, Florida.

Developer of therapeutic medicines designed to treat age-related diseases and improve healthy longevity. The company researches proteins that regulate multiple genes involved in processes like stress resistance, and metabolism and develops novel modulators of a central stress response pathway to modulate aging through genetics, enabling patients to extend the years of healthy living.

Merz Pharmaceuticals is an innovative pharmaceutical company specializing in the research and marketing of drugs for the treatment of neurological and psychiatric diseases. Merz is leading in the field of Alzheimer's research and developed the world's first drug for the treatment of moderate to severe stages of Alzheimer's disease. In the neurological sector, Merz also offers drugs for the treatment of Parkinson's, depression and dystonia.

International Flavors & Fragrances Inc. is a innovator of sensorial experiences that move the world. At the heart of our company, we are fueled by a sense of discovery, constantly asking “what if?” That passion for exploration drives us to co-create unique scents and tastes in fine fragrances and beauty, detergents and household goods, as well as beloved foods and beverages. Our 6,700 team members globally take advantage of leading consumer insights, research and development, creative expertise, and customer intimacy to develop differentiated products.

Operator of an age management medical service offering personalized treatment plans for patients to proactively prevent age-related diseases. The service includes comprehensive evaluations of medical history, lifestyle, physical examination, and laboratory results, with treatment plans integrating diet, exercise, lifestyle management, and metabolic and bioidentical hormonal optimization.

Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, over-the-counter treatments and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 20% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

THE UNIQUE SOTTOPELLE® DOSING APPLICATION The SottoPelle® Dosing Application acts as one part of the pellet therapy system.[1] Using informed judgment combined with a specific set of variables for each individual patient, every SottoPelle® practitioner can consistently deliver the correct pellet dosage. This unique web-based computer application (patent pending) sets SottoPelle® apart from every other hormone replacement therapy. That includes other pellet therapies, which often rely on guesswork, trial and error, or standardized dosing.

Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. Its Products are Azelaprag (BGE-105), an apelin receptor APJ agonist that increases weight loss and improves body composition combined with incretin drugs. and BGE-100 is targeting metabolic diseases and neuroinflammation.